Low immunogenicity predicted for emerging avian-origin H7N9

References

• Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; 368:1888 - 97; http://dx.doi.org/10.1056/NEJMoa1304459; PMID: 23577628
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Alert and Response: Human infection with avian influenza A(H7N9) virus – update. 2013 May 17. Retrieved from: http://www.who.int/csr/don/2013_05_17/en/index.html
   Google Scholar
• Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 2013; 381:1916 - 25; http://dx.doi.org/10.1016/S0140-6736(13)60903-4; PMID: 23623390
   PubMed Web of Science ®Google Scholar
• World Health Organization. Number of confirmed human cases for avian influenza A(H7N9) reported to WHO: Report 3 – data in WHO/HQ as of 01 May 2013, 14:45 GMT+1. 2013 May 01. Retrieved from: http://www.who.int/influenza/human_animal_interface/influenza_h7n9/04_ReportWebH7N9Number.pdf
   Google Scholar
• Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, Xiang N, Chen E, Tang F, Wang D, et al. Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China. N Engl J Med 2013; http://dx.doi.org/10.1056/NEJMoa1304617; PMID: 23614499
   PubMed Web of Science ®Google Scholar
• Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y, Neumann G, Saito T, Kawaoka Y, Tashiro M. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill 2013; 18:20453; PMID: 23594575
   PubMedGoogle Scholar
• Smith M. Infection Route of H7N9 Flu Remains Puzzling. MedPage Today 2013 Apr 18. Retrieved from: http://www.medpagetoday.com/InfectiousDisease/URItheFlu/38553
   Google Scholar
• Centers for Disease Control. R.O.C. (Taiwan). Press Release: In response to occurrence of first imported human infection with avian influenza A (H7N9) in Taiwan, Premier Jiang convenes 6th meeting held by CECC for H7N9 influenza to monitor progress in disease prevention efforts by each government agency. 2013 Apr 25. Retrieved from: http://www.cdc.gov.tw/english/info.aspx?treeid=BC2D4E89B154059B&nowtreeid=EE0A2987CFBA3222&tid=A14678FBB1632075
   Google Scholar
• Butler D. Mapping the H7N9 avian flu outbreaks: Where are the 104 human cases confirmed so far, and where might the virus go next? Nature News 2013 Apr 24; Retrieved from: http://www.nature.com/news/mapping-the-h7n9-avian-flu-outbreaks-1.12863
   Google Scholar
• Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945 - 52; http://dx.doi.org/10.1056/NEJMoa0906453; PMID: 19745214
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58:521 - 4; PMID: 19478718
   PubMedGoogle Scholar
• Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179 - 86; http://dx.doi.org/10.1001/jama.289.2.179; PMID: 12517228
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333 - 40; http://dx.doi.org/10.1001/jama.292.11.1333; PMID: 15367555
   PubMed Web of Science ®Google Scholar
• De Groot AS, Ardito M, McClaine EM, Moise L, Martin WD. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 2009; 27:5740 - 7; http://dx.doi.org/10.1016/j.vaccine.2009.07.040; PMID: 19660593
   PubMed Web of Science ®Google Scholar
• Weber CA, Mehta PJ, Ardito M, Moise L, Martin B, De Groot AS. T cell epitope: friend or foe? Immunogenicity of biologics in context. Adv Drug Deliv Rev 2009; 61:965 - 76; http://dx.doi.org/10.1016/j.addr.2009.07.001; PMID: 19619593
   PubMed Web of Science ®Google Scholar
• De Groot AS, Martin W. Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. Clin Immunol 2009; 131:189 - 201; http://dx.doi.org/10.1016/j.clim.2009.01.009; PMID: 19269256
   PubMed Web of Science ®Google Scholar
• Jawa V, Cousens LP, De Groot AS. Immunogenicity of Therapeutic Fusion proteins: Contributory Factors and Clinical Experience. In: Schmidt SR, ed. Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges. Hoboken, NJ: John Wiley and Sons, Inc., 2013:75-90.
   Google Scholar
• Koren E, De Groot AS, Jawa V, Beck KD, Boone T, Rivera D, Li L, Mytych D, Koscec M, Weeraratne D, et al. Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein. Clin Immunol 2007; 124:26 - 32; http://dx.doi.org/10.1016/j.clim.2007.03.544; PMID: 17490912
   PubMed Web of Science ®Google Scholar
• Couch RB, Patel SM, Wade-Bowers CL, Niño D. A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine. PLoS One 2012; 7:e49704; http://dx.doi.org/10.1371/journal.pone.0049704; PMID: 23239968
   PubMed Web of Science ®Google Scholar
• Couch RB, Decker WK, Utama B, Atmar RL, Niño D, Feng JQ, Halpert MM, Air GM. Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans. PLoS One 2012; 7:e50830; http://dx.doi.org/10.1371/journal.pone.0050830; PMID: 23239987
   PubMed Web of Science ®Google Scholar
• De Groot AS, Goldberg M, Moise L, Martin W. Evolutionary deimmunization: an ancillary mechanism for self-tolerance?. Cell Immunol 2006; 244:148 - 53; http://dx.doi.org/10.1016/j.cellimm.2007.02.006; PMID: 17445787
   PubMed Web of Science ®Google Scholar
• De Groot AS, McMurry J, Moise L. Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates. Curr Opin Pharmacol 2008; 8:620 - 6; http://dx.doi.org/10.1016/j.coph.2008.08.002; PMID: 18775515
   PubMed Web of Science ®Google Scholar
• De Groot AS, Bishop EA, Khan B, Lally M, Marcon L, Franco J, Mayer KH, Carpenter CC, Martin W. Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. Methods 2004; 34:476 - 87; http://dx.doi.org/10.1016/j.ymeth.2004.06.003; PMID: 15542374
   PubMed Web of Science ®Google Scholar
• Levitz L, Koita OA, Sangare K, Ardito MT, Boyle CM, Rozehnal J, Tounkara K, Dao SM, Koné Y, Koty Z, et al. Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine. Vaccine 2012; 30:7547 - 60; http://dx.doi.org/10.1016/j.vaccine.2012.10.042; PMID: 23102976
   PubMed Web of Science ®Google Scholar
• Uyeki TM, Cox NJ. Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med 2013; 368:1862 - 4; http://dx.doi.org/10.1056/NEJMp1304661; PMID: 23577629
   PubMed Web of Science ®Google Scholar
• Schanen BC, De Groot AS, Moise L, Ardito M, McClaine E, Martin W, Wittman V, Warren WL, Drake DR 3rd. Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus. Vaccine 2011; 29:3299 - 309; http://dx.doi.org/10.1016/j.vaccine.2011.02.019; PMID: 21349362
   PubMed Web of Science ®Google Scholar
• Ellebedy AH, Ducatez MF, Duan S, Stigger-Rosser E, Rubrum AM, Govorkova EA, Webster RG, Webby RJ. Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets. Vaccine 2011; 29:3335 - 9; http://dx.doi.org/10.1016/j.vaccine.2010.08.067; PMID: 20840835
   PubMed Web of Science ®Google Scholar
• Galli G, Medini D, Borgogni E, Zedda L, Bardelli M, Malzone C, Nuti S, Tavarini S, Sammicheli C, Hilbert AK, et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc Natl Acad Sci U S A 2009; 106:3877 - 82; http://dx.doi.org/10.1073/pnas.0813390106; PMID: 19237568
   PubMed Web of Science ®Google Scholar
• De Groot AS, Bosma A, Chinai N, Frost J, Jesdale BM, Gonzalez MA, Martin W, Saint-Aubin C. From genome to vaccine: in silico predictions, ex vivo verification. Vaccine 2001; 19:4385 - 95; http://dx.doi.org/10.1016/S0264-410X(01)00145-1; PMID: 11483263
   PubMed Web of Science ®Google Scholar
• De Groot AS, Jesdale BM, Szu E, Schafer JR, Chicz RM, Deocampo G. An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. AIDS Res Hum Retroviruses 1997; 13:529 - 31; http://dx.doi.org/10.1089/aid.1997.13.529; PMID: 9135870
   PubMed Web of Science ®Google Scholar
• Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 1998; 160:3363 - 73; PMID: 9531296
   PubMed Web of Science ®Google Scholar
• De Groot AS, Bishop EA, Khan B, Lally M, Marcon L, Franco J, Mayer KH, Carpenter CC, Martin W. Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. Methods 2004; 34:476 - 87; http://dx.doi.org/10.1016/j.ymeth.2004.06.003; PMID: 15542374
   PubMed Web of Science ®Google Scholar
• Yiqi Y. Culls imposed to minimize contact. China Daily. 2013 Apr 18. Retrieved from: http://www.chinadaily.com.cn/cndy/2013-04/18/content_16417457.htm
   Google Scholar
• Calis JJ, de Boer RJ, Keşmir C. Degenerate T-cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire. PLoS Comput Biol 2012; 8:e1002412; http://dx.doi.org/10.1371/journal.pcbi.1002412; PMID: 22396638
   PubMed Web of Science ®Google Scholar